Minerva Neurosciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGMinerva Neurosciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 37), showing significant lag compared to the market leaders. Earnings contraction of 154% provides fundamental context to the price action. Investors should exercise caution due to high volatility (97% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.68 | +5.22% | ABOVE |
| 50 SMA | $5.22 | -5.80% | BELOW |
| 100 SMA | $5.87 | -16.21% | BELOW |
| 150 SMA | $5.30 | -7.19% | BELOW |
| 200 SMA | $4.80 | +2.50% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NERV in an uptrend right now?
NERV has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is NERV overbought or oversold?
NERV's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is NERV outperforming the market?
NERV has a Relative Strength (RS) Rating of 37 out of 99. NERV is currently lagging the broader market.
Where is NERV in its 52-week range?
NERV is trading at $4.92, which is 39% of its 52-week high ($12.46) and 31% above its 52-week low ($1.59).
How volatile is NERV?
NERV has a Beta of 1.57 and 52-week volatility of 97%. It's more volatile than the S&P 500 - expect bigger swings.